Condition
Gastritis H Pylori
Total Trials
7
Recruiting
0
Active
1
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 7 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
43%
3 trials in Phase 3/4
Results Transparency
0%
0 of 4 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (2)
P 3 (1)
P 4 (2)
Trial Status
Completed4
Unknown2
Active Not Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (7)
Showing 7 of 7 trials
NCT07224048Phase 4Active Not Recruiting
Helicobacter Pylori Screening and Treatment in the At-risk South Florida Community-AIM 2
NCT06269380Not ApplicableCompletedPrimary
Evaluation of Antral Biopsies Obtained in Normal Esophagogastroduodenoscopy
NCT06015763Not ApplicableUnknownPrimary
Correlation Between H.Pylori Colonization and Gastritis
NCT05101395CompletedPrimary
Prevalence of H. Pylori Gastritis in Sleeve Gastrectomy Specimens
NCT04652284Phase 3Unknown
Effectiveness of Rifabutin for Treatment of Helicobacter Pylori
NCT04769583Phase 4CompletedPrimary
14-day Quadruple Therapy Versus Triple Therapy in HP Eradication
NCT04489030CompletedPrimary
Magnifying NBI Endoscopy for Gastric Condition
Showing all 7 trials